网格蛋白将TGF-β在肝癌中的作用切换为促肿瘤生成
该研究探讨网格蛋白在肝细胞TGF-β信号传导及肝癌中的作用,通过分析人和小鼠肝肿瘤中网格蛋白重链表达、体外敲低或过表达CLTC以及生物信息学分析HCC患者预后。发现网格蛋白表达在肝肿瘤发生中升高,敲低CLTC损伤TGF-β的抗凋亡信号但保留SMAD磷酸化,CLTC高表达与TGFB1正相关且高表达患者预后更差、总生存更低。
要点
- 网格蛋白重链在人和小鼠肝肿瘤发生中表达增加。
- CLTC敲低保留TGF-β诱导的SMAD磷酸化但损伤EGFR反式激活的抗凋亡信号。
- HCC中TGFB1与CLTC正相关,两者高表达患者预后更差、总生存更低。
核心结论
- 网格蛋白在肝肿瘤发生中通过促进非经典促肿瘤TGF-β通路发挥新作用。
- 人HCC样本中CLTC表达可能有助于筛选受益于TGF-β靶向治疗的患者。
研究设计与样本
- 采用实时PCR和免疫组化分析人(CLTC)和小鼠(Cltc)肝肿瘤中网格蛋白重链表达。
- 体外用siRNA瞬时敲低或过表达CLTC分析其对TGF-β和EGFR信号的影响。
- 用生物信息学分析CLTC和TGFB1表达对HCC患者预后和总生存的影响。
主要发现
- 网格蛋白表达在人和小鼠肝肿瘤发生过程中增加。
- CLTC敲低细胞对TGF-β仍磷酸化SMADs(经典信号),但抗凋亡信号(EGFR反式激活)受损。
- HCC细胞中功能缺失或获得实验揭示网格蛋白在抑制TGF-β诱导的凋亡及上调促凋亡靶点NOX4中起关键作用。
- 侵袭性HCC细胞的自分泌TGF-β信号上调CLTC表达,将其作用切换为促肿瘤生成。
- HCC细胞和患者中TGFB1与CLTC呈正相关,且TGFB1和CLTC高表达患者预后更差、总生存更低。
临床怎么用
- CLTC表达可能作为HCC患者筛选TGF-β靶向治疗的潜在生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Upon ligand binding, tyrosine kinase receptors, such as epidermal growth factor receptor (EGFR), are recruited into clathrin-coated pits for internalization by endocytosis, which is relevant for signalling and/or receptor degradation. In liver cells, transforming growth factor-β (TGF-β) induces both pro- and anti-apoptotic signals; the latter are mediated by the EGFR pathway. Since EGFR mainly traffics via clathrin-coated vesicles, we aimed to analyse the potential role of clathrin in TGF-β-induced signalling in liver cells and its relevance in liver cancer. METHODS: Real-Time PCR and immunohistochemistry were used to analyse clathrin heavy-chain expression in human (CLTC) and mice (Cltc) liver tumours. Transient knockdown (siRNA) or overexpression of CLTC were used to analyse its role on TGF-β and EGFR signalling in vitro. Bioinformatic analysis was used to determine the effect of CLTC and TGFB1 expression on prognosis and overall survival in patients with hepatocellular carcinoma (HCC). RESULTS: Clathrin expression increased during liver tumorigenesis in humans and mice. CLTC knockdown cells responded to TGF-β phosphorylating SMADs (canonical signalling) but showed impairment in the anti-apoptotic signals (EGFR transactivation). Experiments of loss or gain of function in HCC cells reveal an essential role for clathrin in inhibiting TGF-β-induced apoptosis and upregulation of its pro-apoptotic target NOX4. Autocrine TGF-β signalling in invasive HCC cells upregulates CLTC expression, switching its role to pro-tumorigenic. A positive correlation between TGFB1 and CLTC was found in HCC cells and patients. Patients expressing high levels of TGFB1 and CLTC had a worse prognosis and lower overall survival. CONCLUSIONS: This work describes a novel role for clathrin in liver tumorigenesis, favouring non-canonical pro-tumorigenic TGF-β pathways. CLTC expression in human HCC samples could help select patients that would benefit from TGF-β-targeted therapy. LAY SUMMARY: Clathrin heavy-chain expression increases during liver tumorigenesis in humans (CLTC) and mice (Cltc), altering the cellular response to TGF-β in favour of anti-apoptotic/pro-tumorigenic signals. A positive correlation between TGFB1 and CLTC was found in HCC cells and patients. Patients expressing high levels of TGFB1 and CLTC had a worse prognosis and lower overall survival. CLTC expression in HCC human samples could help select patients that would benefit from therapies targeting TGF-β.
引用
- Caballero-Díaz D, Bertran E, Peñuelas-Haro I, et al. Clathrin switches transforming growth factor-β role to pro-tumorigenic in liver cancer. J Hepatol. 2019. PMID: 31562907. doi:10.1016/j.jhep.2019.09.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。